Medicine & Life Sciences
African Americans
31%
Alleles
29%
Atrial Fibrillation
38%
Autoantibodies
27%
Brain Infarction
54%
Breast Neoplasms
41%
Cardiac Arrhythmias
23%
Carotid Artery Diseases
37%
Clinical Trials
26%
Clinical Trials, Phase I
29%
Colonoscopy
39%
Colorectal Neoplasms
52%
Confidence Intervals
32%
Coronary Artery Disease
72%
Coronary Disease
23%
Cystic Fibrosis
26%
Diabetes Mellitus
38%
Early Detection of Cancer
41%
Elderly
60%
Endodontics
23%
Heart Diseases
25%
Heart Failure
46%
Hispanic Americans
38%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
36%
Hypertension
33%
Incidence
66%
Left Ventricular Hypertrophy
27%
Maximum Tolerated Dose
39%
Mortality
49%
Myocardial Infarction
62%
Myocardial Ischemia
26%
Neoplasms
57%
Non-Small Cell Lung Carcinoma
30%
Odds Ratio
79%
Peripheral Arterial Disease
48%
Propranolol
27%
Prospective Studies
25%
Radiosurgery
54%
Radiotherapy
43%
Random Allocation
29%
Randomized Controlled Trials
32%
Regression Analysis
31%
Sample Size
100%
Serum
34%
Stroke
48%
Stroke Volume
27%
Survival
62%
Systemic Lupus Erythematosus
36%
Systemic Scleroderma
56%
Therapeutics
32%
Mathematics
Binary
10%
Binary Data
19%
Binary Outcomes
39%
Categorical or nominal
8%
Chi-square
8%
Chi-squared test
11%
Clinical Trials
33%
Closed-form
10%
Clustered Data
24%
Common ratio
11%
Contingency Table
8%
Correlated Binary Data
7%
Correlation Structure
24%
Count
11%
Design
16%
Drop out
20%
Estimator
11%
Evaluation
16%
Exact Test
9%
Generalized Estimating Equations
34%
Intracluster Correlation
13%
K-group
18%
Missing Data
23%
Misspecification
7%
Mixed Model
6%
Number of Clusters
6%
Observation
15%
Odds Ratio
9%
Performance
11%
Power Analysis
11%
Proportion
12%
Randomisation
23%
Randomized Trial
19%
Rate of change
25%
Repeated Measurement Designs
6%
Repeated Measurements
45%
Response Time
11%
Sample Size
69%
Sample Size Calculation
57%
Sample Size Determination
10%
Significance level
5%
Simulation Study
20%
Slope
9%
Statistic
6%
Test Statistic
5%
Treatment Effects
11%
Trends
9%
Type I error
15%
Wedge
8%
Weighting
6%